Search

everythinglearnresearchcommunity

for

Search:↓

Antiandrogenic pretreatment for women with PCOS does not improve fertility outcomes and delays pregnancy.

Curcumin, EGCG, barringtozenol, and finasteride are effective VEGFR inhibitors.

Treating PCOS patients with HP HMG significantly raises the risk of ovarian hyperstimulation syndrome, needing careful dose management.

Proxalutamide helps COVID-19 patients get rid of the virus faster and recover quicker.

L-Selectin and adiponectin can help identify PCOS patients who respond to Metformin treatment.

Cyproterone acetate and ethinylestradiol effectively reduce hirsutism and acne in women.

Multicomponent crystals in microneedles improve drug delivery for hair loss treatment.

5ARIs like finasteride can help prevent prostate cancer and treat BPH, but guidelines should be updated to reflect this.

Nanocapsules can improve clobetasol delivery to hair follicles, reducing side effects.

Sustained-release sodium valproate is effective in treating epilepsy, with some side effects influenced by genetics.

PCOS treatment should be personalized, using birth control pills or metformin for symptoms, with lifestyle changes being essential.

Simvastatin/ezetimibe may help some patients with severe alopecia areata regrow hair.

Non-viral delivery systems and stimuli-responsive nanoformulations can improve CRISPR-Cas9 gene therapy.

Hexahydrobenzo[f]quinolines are effective at blocking the enzyme 5α-reductase.

Blood removal and birth control pills both helped with hormone levels in women with PCOS, but birth control was better for regular periods and blood removal had fewer side effects.

Chitosan-decorated nanoparticles improve skin delivery of finasteride, with PS404-b-PAA63 being most effective.

Pegylated interferon-alpha 2a can cause a rare nerve disorder, but early treatment can lead to full recovery.

The FDA approved using Cialis with Proscar for better treatment options.

Nanocarriers like liposomes and cyclodextrins improve how angiotensin-(1-7) is delivered in the body.

The study found that heart disease is common in people with PCOS and that being overweight is a major risk factor; lifestyle changes and medication are important for management.

In 2002, various drugs caused serious side effects, including vitamin B12 deficiency, heart issues, blindness, hypersexuality, allergic reactions, blood clotting problems, pupil dilation, capillary leak syndrome, muscle breakdown, hepatitis, skin reactions, and lupus.

Nanoporous silica entrapped lipid-drug complexes significantly improve the solubility and absorption of drugs that don't dissolve well in water.

Improved genetic diagnosis of PCOS can lead to better patient outcomes.

Cosmetovigilance and clinical pharmacists can enhance safety in cosmetic treatments, especially for those with diabetes.

The guideline refines PCOS diagnosis, promotes a healthy lifestyle, reviews treatments, and stresses long-term follow-up.

Afatinib, neratinib, and zanubrutinib could be effective against KRASG12C-mutant tumors.

Nano-PROTACs could improve drug targeting and delivery by using nanotechnology.

Treatments for Polycystic Ovary Syndrome (PCOS) focus on reducing symptoms, restoring regular periods, and helping with pregnancy. Common treatments include hormone suppressors, fertility drugs, and insulin-sensitising agents.

Certain medications can reduce mortality risk in COPD patients, but others can increase risks of cardiovascular issues, postoperative delirium, and other adverse effects.